PT  - JOURNAL ARTICLE
AU  - Vanesa González-Bellido
AU  - Verónica Velaz-Baza
AU  - Elena Blanco-Moncada
AU  - Maria del Carmen Jimeno Esteo
AU  - Juan Nicolás Cuenca-Zaldívar
AU  - Alicia Colombo-Marro
AU  - Márcio Vinícius Fagundes Donadio
AU  - Rodrigo Torres-Castro
TI  - Immediate Effects and Safety of High-Frequency Chest Wall Compression Compared to Airway Clearance Techniques in Non-Hospitalized Infants With Acute Viral Bronchiolitis
AID  - 10.4187/respcare.08177
DP  - 2020 Nov 03
TA  - Respiratory Care
PG  - respcare.08177
4099  - http://rc.rcjournal.com/content/early/2020/11/03/respcare.08177.short
4100  - http://rc.rcjournal.com/content/early/2020/11/03/respcare.08177.full
AB  - BACKGROUND: No studies have investigated the use and safety of high-frequency chest wall compression (HFCWC) for non-hospitalized infants with acute viral bronchiolitis (AVB). The aim of the present study was to evaluate the immediate effects and safety of HFCWC as compared to airway clearance techniques in children with AVB.METHODS: In this randomized clinical trial in non-hospitalized infants (0–12 months old) with mild to moderate AVB, children were randomized into 2 groups: airway clearance techniques (20 min of prolonged slow expiration and provoked cough) or HFCWC (15 min). A single session was performed and children were evaluated at baseline and at 10 min and 20 min after treatments. Outcomes measures were the Wang severity score, SpO2, sputum wet-weight, and the presence of adverse events.RESULTS: A total of 91 infant subjects, mean age 7.9 ± 2.6 months, were included. Significant (P = .004) between-group differences were found in the Wang score, which was 0.28 points lower in the airway clearance techniques group. There was a greater increase of infants classified as normal and a greater decrease of those classified as mild according to the Wang score when airway clearance techniques were used compared to the use of HFCWC (P = .009). The sputum wet-weight was lower in subjects treated with the airway clearance techniques (P < .001). Although SpO2 improved in both groups, no differences were found between them. There was also no difference for adverse events, and the majority of children did not present any adverse events after 20 min.CONCLUSIONS: The use of HFCWC induced similar clinical effects as airway clearance techniques and was safe for non-hospitalized infants with AVB. Both techniques reduced respiratory symptoms and acutely improved SpO2. (ClinicalTrials.gov: NCT03835936.)